From our private database of 46,500+ case briefs, written and edited by humans—never with AI.
United States v. Generix Drug Corp.
United States Supreme Court
460 U.S. 453 (1983)
- Written by Alex Ruskell, JD
Facts
The Food and Drug Administration required Generix Drug Corp. (defendant) to have approved new-drug applications before it could market its generic drugs. Generix argued that its generic drugs were not new drugs under the Food, Drug, and Cosmetic Act because “drug” only referred to the active ingredient and not the product as a whole. Thus, if a pioneer drug with the active ingredient had already received approval, a generic drug with that same active ingredient should not be required to go through the same process because it was not in fact a new drug.
Rule of Law
Issue
Holding and Reasoning (Stevens, J.)
What to do next…
Here's why 832,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,500 briefs, keyed to 994 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.
